Iron Chelators of the Di-2-pyridylketone Thiosemicarbazone and 2-Benzoylpyridine Thiosemicarbazone Series Inhibit HIV-1 Transcription: Identification of Novel Cellular Targets—Iron, Cyclin-Dependent Kinase (CDK) 2, and CDK9
Zufan Debebe(Howard University), Sergeï Nekhai(Howard University), Fatah Kashanchi(George Mason University), Marina Jerebtsova(Children's National), Danuta S. Kalinowski(The University of Sydney), Patricio E. Ray(University of Virginia Health System), David B. Lovejoy(Macquarie University), Des R. Richardson(Griffith University), Pradeep K. Karla(Howard University), Denitra Breuer(Howard University), K. A. Jeevan Kumar(Howard University), Victor R. Gordeuk(University of Illinois Chicago)
Cited by 68
Related Papers
Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
|New England Journal of Medicine|2005|774
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
|Kidney International|2020|548
Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases
|Pharmaceutics|2018|408